CD44 and neoplasm: Aptamers are synthetic oligonucleotides capable of binding to specific targets; they have been used to target molecules overexpressed on the tumor cell surface, such as nucleolins and CD44, or in the tumor microenvironment, such as IL-4Rα [40] (Figure 2).